Unlike healthy BMECs, cells derived from MS patients were larger in size and showed impaired junctional integrity (particularly with V-cadherin, claudin-5, and occludin), impaired barrier properties, and impaired efflux pump activity. This evidence concerns the gene OCLN and myeloid sarcoma.